MeSH Browser

MeSH Heading: Bucladesine
Tree Number(s): D03.633.100.759.646.138.395.250; D13.695.462.200.250; D13.695.667.138.395.250; D13.695.827.068.395.250
Unique ID: D003994
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D003994
Scope Note: A cyclic nucleotide derivative that mimics the action of endogenous CYCLIC AMP and is capable of permeating the cell membrane. It has vasodilator properties and is used as a cardiac stimulant. (From Merck Index, 11th ed)
Entry Term(s): (But)(2) cAMP; Bucladesine, Barium (1:1) Salt; Bucladesine, Disodium Salt; Bucladesine, Monosodium Salt; Bucladesine, Sodium Salt; DBcAMP; Dibutyryl Adenosine 3,5 Monophosphate; Dibutyryl Adenosine-3',5'-Monophosphate; Dibutyryl Cyclic AMP; N',O'-Dibutyryl-cAMP; N(6),0(2')-Dibutyryl Cyclic AMP
Registry Numbers: 63X7MBT2LQ; 16980-89-5; 19436-29-4; 19463-02-6; 35718-25-3
Related Numbers: 16980-89-5; 19436-29-4; 19463-02-6; 35718-25-3; 362-74-3
CAS Type 1 Name: Adenosine, N-(1-oxobutyl)-, cyclic 3',5'-(hydrogen phosphate) 2'-butanoate
Public MeSH Note: 94; was DIBUTYRYL CYCLIC AMP 1974-93
Online Note: use BUCLADESINE to search DIBUTYRYL CYCLIC AMP 1974-93
History Note: 94; was DIBUTYRYL CYCLIC AMP 1974-93
Date Established: 1974/01/01
Date of Entry: 1999/01/01
Revision Date: 2016/05/27

Allowable Qualifiers: administration & dosage (AD)

adverse effects (AE)

agonists (AG)

analogs & derivatives (AA)

analysis (AN)

antagonists & inhibitors (AI)

blood (BL)

cerebrospinal fluid (CF)

chemical synthesis (CS)

chemistry (CH)

classification (CL)

economics (EC)

genetics (GE)

history (HI)

immunology (IM)

isolation & purification (IP)

metabolism (ME)

pharmacokinetics (PK)

pharmacology (PD)

poisoning (PO)

radiation effects (RE)

standards (ST)

supply & distribution (SD)

therapeutic use (TU)

toxicity (TO)

urine (UR)

Concept UI: M0006259
Registry Numbers: 63X7MBT2LQ
Related Numbers: 16980-89-5; 19436-29-4; 19463-02-6; 35718-25-3; 362-74-3
Scope Note: A cyclic nucleotide derivative that mimics the action of endogenous CYCLIC AMP and is capable of permeating the cell membrane. It has vasodilator properties and is used as a cardiac stimulant. (From Merck Index, 11th ed)
Terms: Bucladesine Preferred Term
Term UI T012118
Date01/01/1999
LexicalTag NON
ThesaurusID; Dibutyryl Adenosine 3,5 Monophosphate
Term UI T012113
Date07/27/1984
LexicalTag NON
ThesaurusID UNK (19XX); Dibutyryl Adenosine-3',5'-Monophosphate
Term UI T012114
Date03/16/1977
LexicalTag NON
ThesaurusID UNK (19XX); Dibutyryl Cyclic AMP
Term UI T012115
Date12/18/1992
LexicalTag NON
ThesaurusID NLM (1994); N',O'-Dibutyryl-cAMP
Term UI T012116
Date04/23/1988
LexicalTag NON
ThesaurusID UNK (19XX); N(6),0(2')-Dibutyryl Cyclic AMP
Term UI T012117
Date09/18/1981
LexicalTag NON
ThesaurusID UNK (19XX); (But)(2) cAMP
Term UI T012112
Date11/20/1980
LexicalTag NON
ThesaurusID UNK (19XX); DBcAMP
Term UI T670371
Date04/03/2006
LexicalTag ABB
ThesaurusID NLM (2007)

Bucladesine MeSH Descriptor Data 2024